The Europe cholesterol testing market is expected to reach USD 2,572.27 million by 2025, from USD 1,408.99 million in 2017 growing at a CAGR of 7.9% in the forecast period 2018 to 2025.
The major factors driving the market are technological advancements in cholesterol testing, growing number of cardiovascular diseases and obesity, higher growing number of geriatric population, rising awareness and acceptance of preventive healthcare, increasing cholesterol home/self-testing market. The cholesterol testing market in the Europe region is leading in UK.
The key market players for Europe Cholesterol Testing Market are listed below;

Abbott Laboratories
Accutech, LLC
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Prima Lab SA
Quest Diagnostics, Inc.
Home Access Health Corporation
F. Hoffmann-La Roche AG
Siemens AG
Sigma-Aldrich Corp.

The market is further segmented into;
Product Type
Test
Test Type
Prescription Mode
End-users

The Europe cholesterol testing market is segmented on the basis of product type, test, test type, prescription mode, and end-users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
The Europe cholesterol testing market is segmented based on product type into testing strips and test kits. In 2018, test kits segment is expected to dominate the Europe cholesterol testing market with 64.6% market share and is expected to reach USD 1,676.27 million by 2025, growing at the highest CAGR of 8.0% in the forecast period 2018 to 2025.
The Europe cholesterol testing market is segmented on the basis of test into lipid panel test/complete lipid profile, apolipoprotein b test, apolipoprotein A-1 test, APOE genotyping test, apolipoprotein CII and others. In 2018, lipid panel test/complete lipid profile segment is expected to dominate the Europe cholesterol testing market with 44.2% market share and is expected to reach USD 1,172.34 million by 2025, growing at the highest CAGR of 8.4% in the forecast period 2018 to 2025.
The Europe cholesterol testing market is segmented on the basis of test type into non-invasive and invasive. In 2018, invasive market segment is expected to dominate the Europe cholesterol testing market with 73.5% market share and is expected to reach USD 1,868.58 million by 2025, growing at a CAGR of 7.7% in the forecast period 2018 to 2025. However, non-invasive is expected to grow at the highest CAGR of 8.4% in the forecast period, and is expected to reach USD 703.69 million in 2025 from USD 371.89 million in 2017.
The Europe cholesterol testing market is segmented on the basis of prescription mode into over the counter and prescription based. In 2018, prescription based market segment is expected to dominate the Europe cholesterol testing market with 80.2% market share and is expected to reach USD 2,093.98 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
The Europe cholesterol testing market is segmented on the basis of prescription mode into end users, clinics, hospitals, ambulatory centers, homecare and diagnostic centers. In 2018, hospitals are expected to dominate the Europe cholesterol testing market with 48.4% market share and are expected to reach USD 1,281.24 million by 2025, growing at the highest CAGR of 8.4% in the forecast period 2018 to 2025.
.Based on geography, the Europe cholesterol testing market is segmented into geographical regions, such as,
Germany,
United Kingdom,
France,
Spain,
Italy,
Russia,
Turkey,
Belgium,
Nether lands,
Switzerland,
Rest of Europe
Covered in this report
The report covers the present scenario and the growth prospects of the Europe cholesterol testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.